Skip to content
Screener

Apyx Medical Corporation APYX Q2 2026 earnings

Reported August 6, 2026 · After market close

Revenue$13.9MBeat by $708.6K
EPS-$0.07Beat by $0.01
Revenue estimate$13.2M
EPS estimate-$0.08
“We are excited by the increasing demand for AYON throughout the U.S. market, which we believe reflects the successful execution of our commercial strategy. As a result, we reported 28% growth for the Surgical Aesthetics segment and expect AYON to continue to drive growth through the second half of the year. U.S. Surgeons continue to recognize the value of an all-in-one body contouring platform that brings together the technologies they rely on every day. With the recent FDA clearance of AYON's power liposuction capability, we are executing a measured rollout with key surgeons ahead of a initial commercial shipments in June. Alongside the expanding body of clinical evidence supporting Renuvion, these milestones reinforce our confidence in the long-term growth opportunity for our business.”
Charlie Goodwin

Next report

Nov 5, 2026 (in 2 months)
Revenue estimate$13.3M
EPS estimate-$0.07

Valuation & ratios

Valuation

as of 09/18/26
See full
Market cap$127.64M+50.7%
Enterprise value$135.96M+43.9%
P/S2.3×+0.5×

FAQ

When did Apyx Medical Corporation report Q2 2026 earnings?
Apyx Medical Corporation (APYX) reported Q2 2026 earnings on August 6, 2026 after market close.
What were Apyx Medical Corporation's Q2 2026 revenue and EPS?
Apyx Medical Corporation reported revenue of $13.9M and eps of $-0.07 for Q2 2026.
Did Apyx Medical Corporation beat estimates in Q2 2026?
Revenue beat the consensus estimate of $13.2M by $708.6K. EPS beat the consensus estimate of $-0.08 by $0.01.
How did Apyx Medical Corporation's Q2 2026 results compare year-over-year?
Compared to the same quarter a year prior, revenue grew 22.1% from $11.4M a year earlier and eps grew 22.2% from $-0.09.
Where can I find Apyx Medical Corporation's Q2 2026 SEC filings?
You can read the 8-K earnings release (0001437749-26-026262) and the 10-Q periodic report (0001437749-26-026346) directly on SEC EDGAR. The filing index links above go to sec.gov.